Intermittent hypoxia treatment for sleep apnea patients
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests if brief periods of low oxygen (intermittent hypoxia) can change how immune cells work in people with moderate to severe sleep apnea. It may help understand new ways to reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 20 years old.
- You must have moderate to severe sleep apnea (AHI of 15 or higher).
- You must not have any condition that affects your immune system, such as cancer, autoimmune disease, diabetes, or kidney disease.
- You must be willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors understand how to better adjust sleep apnea breathing machines by measuring your airway. You'll have a simple breathing test and overnight sleep study to help improve treatment.
This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.
This study is improving how doctors classify obstructive sleep apnea (a condition where your breathing stops and starts during sleep). It focuses on sleepiness and heart-related risks to help guide treatment. If you are 40 or older and have untreated OSA, you may be able to join.
This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.
This study looks at how repeated episodes of low oxygen during sleep affect the body in people with severe sleep apnea. It may help researchers understand what causes symptoms and long-term risks, which could guide better treatment decisions.
This trial studies whether mild, controlled low oxygen during sleep can change sleep apnea symptoms and related blood pressure issues. It mainly looks at people with newly diagnosed, untreated sleep apnea and early high blood pressure.
Hear when a new Obstructive Sleep Apnea (OSA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.